Azenta approves restructuring plan within multiomics segment on October 5, 2026
AZTA•Azenta approved a restructuring plan involving workforce reductions and the closure of three North American multiomics lab sites. It estimates pre-tax charges of $11 million to $13 million, expects to recognize them in fiscal 2027 and aims to complete the actions by March 31, 2027.
1. Restructuring plan
Azenta approved a restructuring plan within its multiomics segment on October 5, 2026, according to an SEC filing. The plan includes workforce reductions and the closure of three multiomics lab sites in North America.
2. Costs and timing
Azenta estimates aggregate pre-tax charges of $11 million to $13 million. It expects to recognize the charges in the fiscal year ending September 30, 2027, and complete the actions by March 31, 2027.
